Our results confirm the important role of YARS1 in the immune microenvironment of bladder cancer, as YARS1 is not only significantly associated with a variety of immunostimulatory and immunoinhibitor factors, but also there is a significant relationship between YARS1 and a variety of immune cell infiltrations. Here, YARS1 is linked to urinary bladder carcinoma.